Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an analysis on Nike stock, Costco stock and PG stock.

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
27 Dec 2025, 20:49 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to do an analysis on Nike stock, Costco stock and PG stock.
Source overview

AI-generated source summary

The analysis highlights three stocks: VICI, FOUR, and HD. VICI is currently trading at a P/FFO of 11x, down from historical averages, with a dividend yield of 6.4%, considered sustainable. Its outlook for 2026 shows negative growth, but the market recovery case suggests potential for improvement. FOUR is considered undervalued by the speaker, with significant buyback programs and strong growth in earnings per share. HD's outlook for 2026 is negative, with concerns about mortgage rates and housing market performance, but its buyback program and dividend yield are noted as positives.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
2
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
2
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
2 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.6
Tracked signals
324
Historical success
34.4%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail